Starting in 2022, a provision in the 2017 Tax Cuts and Jobs Act will require companies to start amortizing their R&D investments over five years instead of expensing them in the same year they incur the costs. Congress should repeal the rule. Otherwise, jobs will be lost, and U.S. competitiveness will suffer.